Quality of Anticoagulation Management Among Patients With Atrial Fibrillation

Abstract

ATRIAL FIBRILLATION (AF) is the second strongest risk factor for stroke and can increase the risk for stroke 5-fold.¹ Randomized trials have shown that treatment with warfarin sodium decreases the risk for stroke by 60% to 70% in comparison with a decrease of 20% to 25% with aspirin.² Various guidelines and consensus statements support the use of warfarin among patients with AF.^3,4